Professor, Radiation Oncology, University of Texas Medical School at Houston
Radiation Oncology
Dr. Ritsuko Komaki, MD
|
|
Give Review
Ritsuko Komaki is an expert in the field of Radiation Oncology. She graduated from Medical College of Wisconsin Affiliated Hospitals. She has 4 awards "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Super Doctor". Ritsuko Komaki has written publications. She has 95 publications published with PubMed. The lastest paper is: 'MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.' She accepts all Medicare patients.
Publications
- NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.
- Prospective Study of Patient-Reported Symptom Burden in Patients with Non-Small Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.
- PDL1 Regulation by p53 via miR-34.
- A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Canc...
- Comparison of Locoregional versus Extended Locoregional Radiation Volumes for Patients with Nonmetastatic Gastro-esophageal Junction Carcinomas.
- Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...
- Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma.
- A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.
- Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.
- Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.
- Use of Simultaneous Radiation Boost Achieves High Control Rates in Patients With Non-Small-Cell Lung Cancer Who Are Not Candidates for Surgery or Conventional Chemorad...
- Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.
- Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
- Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-...
- Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer.
- Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?
- Lymphopenia association with gross tumor volume and lung v5 and its effects on non-small cell lung cancer patient outcomes.
- EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324.
- Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.
- Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
- Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zo...
- Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
- Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.
- Can Patient Comorbidities Be Included in Clinical Performance Measures for Radiation Oncology?
- Failure Patterns Relative to Radiation Treatment Fields for Stage II-IV Thymoma.
- Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy.
- Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer.
- On the interplay effects with proton scanning beams in stage III lung cancer.
- Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer.
- Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive.
- Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter Study.
- Progress in the management of limited-stage small cell lung cancer.
- Factors Associated with Local-Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer.
- Kie Kian Ang, M.D. Ph.D., 1950-2013.
- ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.
- Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiotherapy.
- Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies.
- Cardiac (18)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.
- Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.
- Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance.
- Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.
- Predictors of postoperative complications after trimodality therapy for esophageal cancer.
- Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation.
- Reply to V.R. Bhatt et al and M.C. Chamberlain.
- Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer.
- Surgery Is an Essential Component of Multimodality Therapy for Patients with Locally Advanced Esophageal Adenocarcinoma.
- Phase 1 Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Non-Small Cell Lung Cancer.
- Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer ...
- The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy ...
- Aortic dose constraints when reirradiating thoracic tumors.
- Modulation of c-Met signaling and cellular sensitivity to radiation: Potential implications for therapy.
- Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.
- Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer.
- Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer.
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
- Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiati...
- Penetration of Recommended Procedures for Lung Cancer Staging and Management in the United States Over 10 Years: A Quality Research in Radiation Oncology Survey.
- ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.
- Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.
- Predictors of High-grade Esophagitis After Definitive Three-dimensional Conformal Therapy, Intensity-modulated Radiation Therapy, or Proton Beam Therapy for Non-small ...
- Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer.
- C-Met Inhibitor MK-8003 Radiosensitizes c-Met-Expressing Non-Small-Cell Lung Cancer Cells With Radiation-Induced c-Met-Expression.
- Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
- Change in Diffusing Capacity After Radiation as an Objective Measure for Grading Radiation Pneumonitis in Patients Treated for Non-Small-Cell Lung Cancer.
- Phase II Study of Accelerated High-Dose Radiotherapy With Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer: Radiation Therapy Oncology Group Pr...
- Adaptive/Nonadaptive Proton Radiation Planning and Outcomes in a Phase II Trial for Locally Advanced Non-small Cell Lung Cancer.
- Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy.
- Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis.
- Quantifying the Interfractional Displacement of the Gastroesophageal Junction During Radiation Therapy for Esophageal Cancer.
- Changes in Pulmonary Function after Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer.
- Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer.
- Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
- Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
- ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.
- Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cance...
- Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.
- Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III...
- Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an a...
- Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.
- Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.
- Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
- Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.
- The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for pati...
- Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase ...
- Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology.
- Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy.
- What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer.
- Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.
- Critical Structure Sparing in Stereotactic Ablative Radiotherapy for Central Lung Lesions: Helical Tomotherapy vs. Volumetric Modulated Arc Therapy.
- Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
- MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Schools
Hiroshima University Faculty Of Medicine
St MaryS Hospital
Med College Of Wisconsin
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Medical College of Wisconsin Affiliated Hospitals
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1871687673 | |
| NPPES Provider LastName | KOMAKI | |
| NPPES Provider FirstName | RITSUKO | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 32.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 40.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871687673 |
| Last Name Of The Provider | KOMAKI |
| First Name Of The Provider | RITSUKO |
| View All |
Similar Doctors
|
|
Dr. John C. Rambeau Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Theodore K. Yang, MD |
|
|
Dr. Christopher H. Crane, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ervin W. Biles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Blackburn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adeel Kaiser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda M. Fahr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Bradfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward B. Singleton, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter B. Morgan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Phillips Jr., MD |
|
|
Dr. Myrna Godoy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren L. Mayo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chelsea C. Pinnix, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad Tang, MD |